Published 27 June 2026 • By Dr. Megan Tranter
Isocyanates are a family of highly reactive low-molecular-weight compounds containing the –N=C=O functional group, and they remain the single most frequently identified chemical cause of occupational asthma in the industrialized world. Used as cross-linking agents in polyurethane foams, elastomers, adhesives, and two-part coatings, they require close attention from anyone responsible for worker health. Despite decades of regulatory action and engineering intervention, the incidence of isocyanate-induced asthma has plateaued rather than declined, a sobering reminder that conventional exposure control has clear limits and that rigorous industrial hygiene practice still matters.
What You’ll Learn
- Where isocyanates are used and how workers become exposed to them.
- How sensitization develops and why both inhalation and skin contact matter.
- The specific occupational exposure limits for TDI, MDI, and HDI.
- Why isocyanate air sampling is analytically difficult and how biological monitoring helps.
- The practical control and medical surveillance steps an industrial hygienist should implement.
Introduction
The principal commercial isocyanates are toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), and hexamethylene diisocyanate (HDI). Each is a potent respiratory sensitizer capable of inducing asthma at airborne concentrations far below those that cause simple irritation. Because sensitized workers can react to low exposures, isocyanates demand a control philosophy built on prevention of sensitization in the first place rather than on managing concentrations after disease appears. This post sets out the toxicology, the limits, and the assessment and control practices that together define a defensible isocyanate program.
Sources and Industrial Uses
TDI dominates flexible foam production, MDI is favored in rigid foams and structural adhesives because of its lower volatility, and HDI is the workhorse of two-component automotive refinish and aerospace coatings. Exposure arises during foam pouring, spray application, thermal decomposition of cured polyurethane during welding, grinding, or fire, and the handling of partially cured prepolymers. Because spray operations aerosolize both monomer and oligomeric isocyanate species, conventional vapor-phase sampling can substantially underestimate the true airborne burden. Understanding the physical state of the airborne contaminant is therefore central to any assessment of gases and vapors in polyurethane operations.
Mechanisms of Sensitization and Disease
Isocyanate asthma is predominantly an immunologically mediated, sensitizer-induced disease. Following an asymptomatic latency period, susceptible workers develop specific airway hyperresponsiveness such that subsequent exposures, even to concentrations far below regulatory limits, provoke bronchoconstriction. The hapten-protein conjugate model holds that reactive isocyanate groups bind self-proteins such as albumin and keratin, generating neoantigens recognized by the immune system. Critically, emerging evidence implicates the dermal route in pulmonary sensitization: HDI-conjugated keratin and urinary biomarkers have been detected in workers with minimal inhalation exposure, suggesting that airborne controls alone may not be sufficient to eliminate disease. This dual-route reality reinforces the value of evaluating all routes of entry rather than inhalation in isolation.
Occupational Exposure Limits
The OSHA permissible exposure limit for TDI is a ceiling of 0.02 ppm (0.14 mg/m³). The ACGIH threshold limit values are stringent: for TDI a TWA of 0.001 ppm with a STEL of 0.005 ppm, and comparable parts-per-billion values for HDI and MDI. NIOSH classifies TDI as a potential occupational carcinogen and recommends controlling exposure to the lowest feasible concentration rather than setting a numeric REL. Several isocyanates carry a sensitizer (SEN) notation, signaling that these limits are intended to limit the proportion of workers who become sensitized rather than to protect already-sensitized individuals, for whom no safe level exists. Because the toxicological endpoint is sensitization rather than simple irritation, these limits illustrate the broader principle that the relationship between dose and response is not always linear, a theme explored in the discussion of dose.
Exposure Assessment Challenges
Sampling isocyanates is analytically demanding. The reactivity and short atmospheric half-life of the monomer, the presence of polymeric and oligomeric species in aerosols, and the need for derivatizing reagents (such as 1-2MP or MAP impingers and treated filters) all complicate quantification. OSHA Methods 42 and 47 and the MDHS 25 procedures address different species and physical states, and no single method captures the full airborne isocyanate spectrum. Biological monitoring of urinary diamine metabolites offers a complementary, route-integrating measure of internal dose, capturing both inhaled and dermally absorbed isocyanate that air sampling alone would miss. The combined gas, vapor, and aerosol behavior of isocyanates places them alongside other reactive contaminants, such as diesel particulate matter and hydrogen sulfide, in which the choice of sampling method strongly shapes the apparent result.
What Industrial Hygienists Should Do
Substitution toward higher-molecular-weight, lower-volatility prepolymers and enclosed dispensing reduces source emissions. Spray operations require local exhaust ventilation, isolated, ventilated spray booths, and supplied-air respiratory protection rather than air-purifying respirators, given the poor warning properties of isocyanates. Impervious gloves and coveralls are essential to interrupt the dermal sensitization pathway. A medical surveillance program incorporating baseline and periodic spirometry, symptom questionnaires, and removal of sensitized workers from further exposure is indispensable, because once sensitized, an individual cannot safely continue work with isocyanates. Air sampling should be paired with biological monitoring, and a documented exposure-control program should be audited against the principles of the hierarchy of controls.
Summary
Isocyanates remain the leading chemical cause of occupational asthma because sensitization can be triggered at exposures well below conventional limits and through the skin as well as the lungs. Effective programs prevent sensitization through enclosure, ventilation, supplied-air respiratory protection, dermal protection, and disciplined medical surveillance that removes affected workers before disease becomes permanent. The guiding principle is simple: for a sensitized worker, there is no safe level, so prevention is the only reliable protection.
Helpful Resources
- NIOSH: Isocyanates topic page
- OSHA: Isocyanates safety and health topic
- Related posts on this site: Exposure to Gases and Vapors and Diesel Particulate Matter.
Bibliography
Agency for Toxic Substances and Disease Registry. (n.d.). Toluene diisocyanate (TDI) and methylenediphenyl diisocyanate (MDI). U.S. Department of Health and Human Services.
American Conference of Governmental Industrial Hygienists. (2026). TLVs and BEIs: Threshold limit values for chemical substances and physical agents and biological exposure indices. ACGIH.
Bello, D., Herrick, C. A., Smith, T. J., Woskie, S. R., Streicher, R. P., Cullen, M. R., Liu, Y., & Redlich, C. A. (2007). Skin exposure to isocyanates: Reasons for concern. Environmental Health Perspectives, 115(3), 328-335. https://doi.org/10.1289/ehp.9557
Bingham, E., & Cohrssen, B. (Eds.). (2012). Patty’s toxicology (6th ed.). John Wiley & Sons.
Coureau, E., Fontana, L., Lamouroux, C., Pelissier, C., & Charbotel, B. (2021). Is isocyanate exposure and occupational asthma still a major occupational health concern? Systematic literature review. International Journal of Environmental Research and Public Health, 18(24), 13181. https://doi.org/10.3390/ijerph182413181
Daniels, R. D. (2018). Occupational asthma risk from exposures to toluene diisocyanate: A review and risk assessment. American Journal of Industrial Medicine, 61(4), 282-292. https://doi.org/10.1002/ajim.22815
Huuskonen, P., Porras, S. P., Scholten, B., Portengen, L., Uuksulainen, S., Ylinen, K., & Santonen, T. (2023). Occupational exposure and health impact assessment of diisocyanates in Finland. Toxics, 11(3), 229. https://doi.org/10.3390/toxics11030229
National Institute for Occupational Safety and Health. (2005). NIOSH pocket guide to chemical hazards: Toluene-2,4-diisocyanate (DHHS [NIOSH] Publication No. 2005-149). U.S. Department of Health and Human Services.
Occupational Safety and Health Administration. (n.d.). OSHA sampling and analytical methods 42 and 47 for diisocyanates. U.S. Department of Labor.
Occupational Safety and Health Administration. (n.d.). Toluene-2,4-diisocyanate (29 CFR 1910.1000, Table Z-1). U.S. Department of Labor.
Plog, B. A., & Quinlan, P. J. (Eds.). (2012). Fundamentals of industrial hygiene (6th ed.). National Safety Council.
Tarlo, S. M., & Lemiere, C. (2014). Occupational asthma. New England Journal of Medicine, 370(7), 640-649. https://doi.org/10.1056/NEJMra1301758